P111 A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)
Title:
P111 A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)
Author:
Harbeck, N. Boileau, J.-F. Modi, S. Kelly, C. Ohno, S. Wu, J. Konpa, A. Herbolsheimer, P. Safdar, S. Zhang, Y. Pusztai, L.